Background: Studies across the world have demonstrated the efficacy of valsartan in
lowering blood pressure in a variety of patient populations, several of them investigated …

An open label, optional titration trial to evaluate the efficacy, tolerability and safety of
Valsartan 80mg od/Valsartan 160mg od in patients with mild to moderate hypertension …

Objectives: To assess the efficacy of valsartan in a different ethnic population than that
studied in international trials. Also to compare the adverse experiences reported in this trial …

A multicenter, randomized, placebo-controlled, double-masked, parallel-group study was
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …

An eight-week open-label optional titration trial to evaluate the efficacy, tolerability and
safety of Valsartan 80 mg/& 160 mg once daily was carried out in patients with mild to …

Objective To evaluate the antihypertensive efficacy and safety of domestic valsartan in the
treatment of mild to moderate essential hypertension. Methods Twenty-one hypertensive …

Angiotensin II antagonists represent a new class of effective and well tolerated
antihypertensive agents. To date many studies with these agents have been of short …

The aim of this study was to evaluate the efficacy and tolerability of valsartan, a new
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …

Background: Valsartan is an established drug for treatment of essential hypertension. It
blocks the action of Angiotensin II irrespective of its sources. A large proportion of patients …

Objective: To compare the efficacy, safety and tolerability of valsartan to an angiotensin-
converting enzyme (ACE) inhibitor, lisinopril, and placebo in patients with mild-to-moderate …